X @The Wall Street Journal

Exclusive: An investor in the narcolepsy drugmaker Avadel Pharmaceuticals plans to call for shareholders to vote out the company’s entire board of directors, ratcheting up pressure on management in a tough environment for biopharmaceutical firms https://t.co/PDJJDjydyQ ...